UnitedHealth Group said in a court filing it is working with Amedisys to identify potential buyers for at least 128 home ...
Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the ...
UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they ...
Two whistleblowers have adequately alleged that Amedisys Inc. violated the False Claims Act by improperly billing Medicare and other federal health-care programs for home health services, a New York ...
Amedisys (NASDAQ:AMED – Get Free Report ... It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes ...
UnitedHealth Group says the Justice Department’s antitrust challenge to its proposed $3.3 billion purchase of Amedisys is wrong on the merits and threatens to deprive consumers of benefits from ...
Zacks Investment Research on MSN2d
Amedisys (AMED) Earnings Expected to Grow: Should You Buy?The market expects Amedisys (AMED) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook ...
They also contend that Amedisys workers would enjoy competitive health and retirement benefits at UnitedHealth Group. “The purported ‘evidence’ the government stitches together in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback